Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Inventory (2022 - 2025)

Mainz Biomed's Inventory history spans 3 years, with the latest figure at $372870.0 for Q4 2024.

  • For Q4 2024, Inventory fell 39.24% year-over-year to $372870.0; the TTM value through Dec 2024 reached $372870.0, down 39.24%, while the annual FY2024 figure was $372870.0, 39.24% down from the prior year.
  • Inventory for Q4 2024 was $372870.0 at Mainz Biomed, down from $613638.0 in the prior quarter.
  • Across five years, Inventory topped out at $613638.0 in Q4 2023 and bottomed at $175469.0 in Q4 2022.
  • The 3-year median for Inventory is $372870.0 (2024), against an average of $387325.7.
  • The largest annual shift saw Inventory soared 249.71% in 2023 before it tumbled 39.24% in 2024.
  • A 3-year view of Inventory shows it stood at $175469.0 in 2022, then skyrocketed by 249.71% to $613638.0 in 2023, then crashed by 39.24% to $372870.0 in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Inventory are $372870.0 (Q4 2024), $613638.0 (Q4 2023), and $175469.0 (Q4 2022).